Fig. 2
Characterization of Monocyte Subsets and Lipid Metabolism Markers in Healthy and Individuals that live with dyslipidemia. (A) Representative dot plots illustrating the traditional gating strategy for CD14 and CD16 to identify classical, intermediate, and non-classical monocytes. Labels differentiate individuals that live with dyslipidemia (n = 23) from healthy controls (n = 17). (B-D) Comparison of the distributions of monocyte subsets between individuals that live with dyslipidemia and healthy groups. (E-G) Analysis of lipid-related markers—ABCA1, PLIN2, and CD36—across monocyte subsets, with marker expression overlaid on CD14/CD16 dot plots to visualize lipid-processing activity within these subsets. Bar graphs display mean ± SD. p-values indicating significance at *p < 0.05.
